FDA ANDA · ANDA074229
NADOLOL
Sponsor: HERITAGE PHARMA
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA074229
TYPE
ANDA
ORIGINAL APPROVAL
1996-08-30
LATEST ACTION
2026-10-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
NADOLOLDiscontinued
NADOLOL 40MG · TABLET · ORAL
NADOLOLDiscontinued
NADOLOL 20MG · TABLET · ORAL
Approval history
2026-10-14Labeling · Supplement 25 · standardAP
2015-04-16Labeling · Supplement 18AP
2015-04-16Labeling · Supplement 16AP
2015-04-16Labeling · Supplement 19 · standardAP
2002-07-29Manufacturing (CMC) · Supplement 7AP
2002-03-12Manufacturing (CMC) · Supplement 6AP
2001-07-31Manufacturing (CMC) · Supplement 4AP
2000-01-28Manufacturing (CMC) · Supplement 3AP
1998-04-06Manufacturing (CMC) · Supplement 1AP
1998-04-06Manufacturing (CMC) · Supplement 2AP
1996-08-30OriginalAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →